Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Immunological properties of engineered nanomaterials.

Dobrovolskaia MA, McNeil SE.

Nat Nanotechnol. 2007 Aug;2(8):469-78. doi: 10.1038/nnano.2007.223. Epub 2007 Jul 29. Review.

PMID:
18654343
[PubMed - indexed for MEDLINE]
2.

Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro.

Dutta T, Agashe HB, Garg M, Balakrishnan P, Kabra M, Jain NK.

J Drug Target. 2007 Jan;15(1):89-98. Erratum in: J Drug Target. 2007 Dec;15(10):721-2. Balasubramanium, Prahlad [corrected to Balakrishnan, Prahlad].

PMID:
17365278
[PubMed - indexed for MEDLINE]
3.

PVP magnetic nanospheres: biocompatibility, in vitro and in vivo bleomycin release.

Guowei D, Adriane K, Chen X, Jie C, Yinfeng L.

Int J Pharm. 2007 Jan 2;328(1):78-85. Epub 2006 Aug 4.

PMID:
17014976
[PubMed - indexed for MEDLINE]
4.

Blood compatibility of novel water soluble hyperbranched polyglycerol-based multivalent cationic polymers and their interaction with DNA.

Kainthan RK, Gnanamani M, Ganguli M, Ghosh T, Brooks DE, Maiti S, Kizhakkedathu JN.

Biomaterials. 2006 Nov;27(31):5377-90. Epub 2006 Jul 18.

PMID:
16854460
[PubMed - indexed for MEDLINE]
5.

Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles.

Föger F, Noonpakdee W, Loretz B, Joojuntr S, Salvenmoser W, Thaler M, Bernkop-Schnürch A.

Int J Pharm. 2006 Aug 17;319(1-2):139-46. Epub 2006 Apr 25. Erratum in: Int J Pharm. 2006 Dec 11;327(1-2):178.

PMID:
16713146
[PubMed - indexed for MEDLINE]
6.

In vitro hemolysis: guidance for the pharmaceutical scientist.

Amin K, Dannenfelser RM.

J Pharm Sci. 2006 Jun;95(6):1173-6.

PMID:
16639718
[PubMed - indexed for MEDLINE]
7.

Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN).

Jin Y, Tong L, Ai P, Li M, Hou X.

Int J Pharm. 2006 Feb 17;309(1-2):199-207. Epub 2005 Dec 27.

PMID:
16377106
[PubMed - indexed for MEDLINE]
8.

Polyethylenimine nanoparticles as efficient transfecting agents for mammalian cells.

Nimesh S, Goyal A, Pawar V, Jayaraman S, Kumar P, Chandra R, Singh Y, Gupta KC.

J Control Release. 2006 Jan 10;110(2):457-68. Epub 2005 Dec 2.

PMID:
16325952
[PubMed - indexed for MEDLINE]
9.

Bioanalytical method validation for macromolecules in support of pharmacokinetic studies.

Smolec J, DeSilva B, Smith W, Weiner R, Kelly M, Lee B, Khan M, Tacey R, Hill H, Celniker A, Shah V, Bowsher R, Mire-Sluis A, Findlay JW, Saltarelli M, Quarmby V, Lansky D, Dillard R, Ullmann M, Keller S, Karnes HT.

Pharm Res. 2005 Sep;22(9):1425-31. Epub 2005 Aug 24. Review.

PMID:
16132353
[PubMed - indexed for MEDLINE]
10.

Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles.

Koziara JM, Oh JJ, Akers WS, Ferraris SP, Mumper RJ.

Pharm Res. 2005 Nov;22(11):1821-8. Epub 2005 Aug 26.

PMID:
16132346
[PubMed - indexed for MEDLINE]
11.

Medical nanotechnology: shortening clinical trials and regulatory pathways?

Ferrari M, Downing G.

BioDrugs. 2005;19(4):203-10. Review.

PMID:
16128604
[PubMed - indexed for MEDLINE]
12.

Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier.

Schubert MA, Müller-Goymann CC.

Eur J Pharm Biopharm. 2005 Sep;61(1-2):77-86.

PMID:
16011893
[PubMed - indexed for MEDLINE]
13.

Nanotechnology for the biologist.

McNeil SE.

J Leukoc Biol. 2005 Sep;78(3):585-94. Epub 2005 May 27. Review.

PMID:
15923216
[PubMed - indexed for MEDLINE]
Free Article
14.

Release kinetics from bio-polymeric nanoparticles encapsulating protein synthesis inhibitor- cycloheximide, for possible therapeutic applications.

Verma AK, Sachin K, Saxena A, Bohidar HB.

Curr Pharm Biotechnol. 2005 Apr;6(2):121-30.

PMID:
15853691
[PubMed - indexed for MEDLINE]
15.

A novel, lipid-free nanodispersion formulation of propofol and its characterization.

Chen H, Zhang Z, Almarsson O, Marier JF, Berkovitz D, Gardner CR.

Pharm Res. 2005 Mar;22(3):356-61.

PMID:
15835740
[PubMed - indexed for MEDLINE]
16.

Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin.

Lewin SN, Mutch DG, Whitcomb BP, Liapis H, Herzog TJ.

Gynecol Oncol. 2005 Apr;97(1):228-33.

PMID:
15790464
[PubMed - indexed for MEDLINE]
17.

[Destruction of human blood cells upon interaction with detonation nanodiamonds in experiments in vitro].

Puzyr' AP, Neshumaev DA, Tarskikh SV, Makarskaia GV, Dolmatov VIu, Bondar' VS.

Biofizika. 2005 Jan-Feb;50(1):101-6. Russian.

PMID:
15759508
[PubMed - indexed for MEDLINE]
18.

Interaction of PLGA nanoparticles with human blood constituents.

Kim D, El-Shall H, Dennis D, Morey T.

Colloids Surf B Biointerfaces. 2005 Feb 10;40(2):83-91.

PMID:
15642458
[PubMed - indexed for MEDLINE]
19.

Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders.

Lim SJ, Lee MK, Kim CK.

J Control Release. 2004 Nov 5;100(1):53-61.

PMID:
15491810
[PubMed - indexed for MEDLINE]
20.

Characterization of aqueous dispersions of Fe(3)O(4) nanoparticles and their biomedical applications.

Cheng FY, Su CH, Yang YS, Yeh CS, Tsai CY, Wu CL, Wu MT, Shieh DB.

Biomaterials. 2005 Mar;26(7):729-38.

PMID:
15350777
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk